Pharmacogenomics allows us to describe how an individual’s genetic variants contribute to their response to drugs. The heterogeneity of the organism’s response to certain drugs represents a problem that affects the well-being of the patient and can generate enormous clinical and economic problems.
Depending on a patient’s genotype, our analysis allows us to determine in a personalized and precise manner which drugs are effective, suggest optimal dosage levels and avoid adverse effects.
Bitgenia analyzes the genetic makeup of individuals to provide information about their response to medications. We select genetic risk markers validated by multiple studies that are significantly associated with the effectiveness of the metabolism of certain drugs.
Our Pharmacogenomics panel comprises an analysis of various genes involved in the metabolism of the following drugs approved by the Food and Drug Administration (FDA). Please let us know if you need an analysis of additional genes and/or drugs.